196 related articles for article (PubMed ID: 35733207)
21. Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best?
Arshad MF; McAllister J; Merchant A; Rab E; Cook J; Eastell R; Balasubramanian S
Postgrad Med J; 2021 Sep; 97(1151):577-582. PubMed ID: 32892159
[TBL] [Abstract][Full Text] [Related]
22. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
[TBL] [Abstract][Full Text] [Related]
23. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
[TBL] [Abstract][Full Text] [Related]
24. A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets.
Szczawinska D; Schnabel D; Letz S; Schöfl C
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1146-53. PubMed ID: 24517148
[TBL] [Abstract][Full Text] [Related]
25. [Familial hypocalciuric hypercalcemia: a new mutation].
Ubetagoyena Arrieta M; Castaño González L; Pérez de Nanclares Leal G; Arruebarrena Lizarraga D; Imaz Murguiondo M; Areses Trapote R
An Pediatr (Barc); 2011 Jan; 74(1):47-50. PubMed ID: 21185797
[TBL] [Abstract][Full Text] [Related]
26. Familial hypocalciuric hypercalcemia associated with crystal deposition disease.
Alix L; Guggenbuhl P
Joint Bone Spine; 2015 Jan; 82(1):60-2. PubMed ID: 25444087
[TBL] [Abstract][Full Text] [Related]
27. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
Grant MP; Stepanchick A; Breitwieser GE
Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
[TBL] [Abstract][Full Text] [Related]
28. Expanding the spectrum of genetic variants in the calcium-sensing receptor (CASR) gene in hypercalcemic individuals.
Nissen PH; Rejnmark L
Clin Endocrinol (Oxf); 2019 Nov; 91(5):683-690. PubMed ID: 31433865
[TBL] [Abstract][Full Text] [Related]
29. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
[TBL] [Abstract][Full Text] [Related]
30. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.
Lietman SA; Tenenbaum-Rakover Y; Jap TS; Yi-Chi W; De-Ming Y; Ding C; Kussiny N; Levine MA
J Clin Endocrinol Metab; 2009 Nov; 94(11):4372-9. PubMed ID: 19789209
[TBL] [Abstract][Full Text] [Related]
31. Cinacalcet therapy in a child with novel homozygous CASR p.Glu353Lys mutation causing familial hypocalciuric hypercalcemia type 1: case report and review of the literature.
Koca SB
Turk J Pediatr; 2023; 65(5):853-861. PubMed ID: 37853976
[TBL] [Abstract][Full Text] [Related]
32. Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.
Kim ES; Kim SY; Lee JY; Han JH; Sohn TS; Son HS; Moon SD
J Bone Miner Metab; 2016 Nov; 34(6):662-667. PubMed ID: 26386835
[TBL] [Abstract][Full Text] [Related]
33. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.
Isaksen T; Nielsen CS; Christensen SE; Nissen PH; Heickendorff L; Mosekilde L
Calcif Tissue Int; 2011 Oct; 89(4):285-94. PubMed ID: 21785908
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of a novel CASR mutation causing familial hypocalciuric hypercalcemia.
Lin CM; Ding YX; Huang SM; Chen YC; Lee HJ; Sung CC; Lin SH
Front Endocrinol (Lausanne); 2024; 15():1291160. PubMed ID: 38487341
[TBL] [Abstract][Full Text] [Related]
35. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
Marx SJ
J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
[TBL] [Abstract][Full Text] [Related]
36. Familial hypocalciuric hypercalcaemia type 1 caused by a novel heterozygous missense variant in the CaSR gene, p(His41Arg): two case reports.
Courtney A; Hill A; Smith D; Agha A
BMC Endocr Disord; 2022 Dec; 22(1):324. PubMed ID: 36536367
[TBL] [Abstract][Full Text] [Related]
37. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
[TBL] [Abstract][Full Text] [Related]
38. Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia.
Höppner J; Lais S; Roll C; Wegener-Panzer A; Wieczorek D; Högler W; Grasemann C
Front Endocrinol (Lausanne); 2021; 12():700612. PubMed ID: 34659108
[TBL] [Abstract][Full Text] [Related]
39. Misleading localization by
Mukhtar NN; Abouzied MEM; Alqahtani MH; Hammami MM
BMC Endocr Disord; 2021 Jan; 21(1):20. PubMed ID: 33499837
[TBL] [Abstract][Full Text] [Related]
40. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
Falchetti A; Gozzini A; Terranegra A; Soldati L; Vezzoli G; Leoncini G; Giusti F; Franceschelli F; Masi L; Tanini A; Cavalli L; Brandi ML
Eur J Endocrinol; 2012 May; 166(5):933-40. PubMed ID: 22315359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
